Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | MEDI |
---|---|---|
10:20 ET | 200 | 25.45 |
11:52 ET | 100 | 25.4801 |
01:31 ET | 300 | 25.48 |
03:19 ET | 318 | 25.29 |
04:00 ET | 302 | 25.2 |
Date | Daily Premium/Discount |
---|---|
08/20/2024 | 0.11% |
08/21/2024 | 0.12% |
08/22/2024 | 0.24% |
08/23/2024 | 0.12% |
08/26/2024 | 0.28% |
08/27/2024 | 0.26% |
08/28/2024 | 0.14% |
08/29/2024 | 0.13% |
08/30/2024 | 0.08% |
09/03/2024 | 0.83% |
09/04/2024 | 0.10% |
09/05/2024 | 0.26% |
09/06/2024 | 0.06% |
09/10/2024 | 0.36% |
09/11/2024 | -0.03% |
09/12/2024 | 0.16% |
09/13/2024 | -0.01% |
09/16/2024 | 0.29% |
09/17/2024 | 0.22% |
09/18/2024 | 0.16% |
09/19/2024 | 0.09% |
09/20/2024 | 0.43% |
09/23/2024 | 0.13% |
09/24/2024 | 0.06% |
09/25/2024 | 0.26% |
09/26/2024 | 0.03% |
09/27/2024 | 0.11% |
09/30/2024 | 0.12% |
10/01/2024 | 0.13% |
10/02/2024 | 0.15% |
10/03/2024 | 0.14% |
10/04/2024 | -0.08% |
10/07/2024 | 0.27% |
10/08/2024 | 0.15% |
10/09/2024 | 0.10% |
10/10/2024 | 0.10% |
10/11/2024 | 0.17% |
10/14/2024 | 0.17% |
10/15/2024 | 0.15% |
10/16/2024 | 0.08% |
10/17/2024 | 0.16% |
10/18/2024 | 0.08% |
10/21/2024 | 0.02% |
10/22/2024 | 0.14% |
10/23/2024 | 0.16% |
10/24/2024 | 0.18% |
10/25/2024 | 0.10% |
10/28/2024 | 0.08% |
10/29/2024 | 0.09% |
10/30/2024 | -0.02% |
10/31/2024 | -0.17% |
11/01/2024 | 0.02% |
11/04/2024 | 0.13% |
11/05/2024 | -0.09% |
11/06/2024 | 0.08% |
11/11/2024 | -0.02% |
11/12/2024 | -0.04% |
11/13/2024 Largest Premium | 1.31% |
11/14/2024 Largest Discount | -0.32% |
11/15/2024 | -0.09% |
US Stock | 79.1% |
---|---|
Non-US Stock | 19.9% |
Cash | 1.0% |
Convertible | 0 |
Non-US Bond | 0 |
Other | 0 |
Healthcare | 99.0% |
---|---|
Basic Mat. | 0 |
Communication Services | 0 |
Consumer Cyclical | 0 |
Consumer Defensive | 0 |
Energy | 0 |
Financial Serv.s | 0 |
Industrials | 0 |
Real Estate | 0 |
Technology | 0 |
Utilities | 0 |
United States | 79.9% |
---|---|
Europe | 0.7% |
Latin America | 0 |
Africa | 0 |
Canada | 0 |
Asia/Oceania | 0 |
Company Name sortable | Position sortable | Allocation sortable | Allocation sortable1 Month Change | Market Value sortable |
---|---|---|---|---|
Ascendis Pharma AS ADR | Long | 15.6% | +1.61% | $2.7M |
AbbVie Inc | Long | 8.0% | 0.00% | $1.4M |
Legend Biotech Corp ADR | Long | 7.6% | 0.00% | $1.3M |
Masimo Corp | Long | 5.4% | 0.00% | $932.8K |
Pfizer Inc | Long | 4.8% | +5.74% | $819.7K |
UnitedHealth Group Inc | Long | 4.7% | 0.00% | $816.3K |
Lantheus Holdings Inc | Long | 4.2% | 0.00% | $730.0K |
Vaxcyte Inc Ordinary Shares | Long | 3.8% | +15.33% | $651.3K |
Option Care Health Inc | Long | 3.4% | 0.00% | $584.0K |
DexCom Inc | Long | 3.2% | 0.00% | $547.3K |
Time Horizon | Star Rating |
---|---|
Overall Rating | Not Rated |
3 Year Rating | Not Rated |
5 Year Rating | Not Rated |
10 Year Rating | Not Rated |
Past performance is no guarantee of future results. The ratings reflect historical risk-adjusted performance, and the overall rating is derived from a weight average of the fund's 3, 5, and 10 year (Morningstar Rating) metrics.
Style Box is calculated only using the long position holdings of the portfolio.
Best Fit Index | Russell 3000 Growth Ind/HC TR USD |
---|---|
Category | |
Sponsor | Harbor Capital Advisors Inc |
Inception | November 16, 2022 |
The investment seeks long-term growth of capital. The fund invests primarily in equity securities, principally common and preferred stocks of companies of any market capitalization. Under normal market conditions, the fund invests at least 80% of its net assets, plus borrowings for investment purposes, in securities of companies principally engaged in the research, development, production, or distribution of products and services related to the health care industry (“health care companiesâ€). It is non-diversified.
Total Net Assets | $17.2M |
---|---|
Shares Out. | 650.0K |
Net Asset Value (NAV) | $25.22 |
Prem/Discount to NAV | -0.09% |
P/E Ratio | 29.0 |
Dividend Yield | 1.83% |
Dividend per Share | 0.46 USD |
Ex-Dividend Date | 12/21/2023 |
Dividend Payment Date | 12/27/2023 |
Beta | --- |
Morningstar Investment Style | Health |
Equity Style | Mid Cap Growth |
Credit Quality / Duration | --- |
Actual Management Fee | 0.80% |
---|---|
Actual Mgmt. Expense Ratio (MER) | 0.80% |